REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,075,979 | -44.3% | 355,360 | +23.0% | 0.14% | -35.6% |
| Q2 2023 | $7,312,742 | -6.7% | 288,927 | +18.7% | 0.22% | -5.9% |
| Q1 2023 | $7,841,911 | +22.0% | 243,462 | -30.1% | 0.24% | +21.9% |
| Q4 2022 | $6,425,261 | -2.8% | 348,064 | +42.1% | 0.20% | -9.3% |
| Q3 2022 | $6,613,000 | +113.9% | 244,917 | +9.5% | 0.22% | +103.8% |
| Q2 2022 | $3,091,000 | -2.0% | 223,631 | +38.3% | 0.11% | +35.9% |
| Q1 2022 | $3,153,000 | -10.8% | 161,695 | -25.3% | 0.08% | +6.8% |
| Q4 2021 | $3,533,000 | -1.1% | 216,497 | +68.8% | 0.07% | +7.4% |
| Q3 2021 | $3,573,000 | – | 128,239 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |